How specific brain cells become overactive in Alzheimer's disease
Automated cell-type-specific electrophysiology for understanding circuit dysregulation in Alzheimer's Disease
['FUNDING_R01'] · EMORY UNIVERSITY · NIH-11297610
This work uses new automated electrical recording tools to look at why certain brain inhibitory cells become overactive in people with Alzheimer's disease.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-11297610 on ClinicalTrials.gov |
What this research studies
From a patient's point of view, researchers are using automated, cell-type-sensitive electrical recordings to watch how parvalbumin-expressing inhibitory neurons fire in models of Alzheimer's. They compare different Alzheimer's models, including ones with common risk factors like APOE-ε4, to see if these neurons become hyperactive before plaques and cell loss appear. The team focuses on whether this hyperactivity could drive faster brain degeneration and cognitive decline. Results could point to specific brain circuits or cell types to target with future therapies.
Who could benefit from this research
Good fit: People with Alzheimer's disease, mild cognitive impairment, or those at higher genetic risk (for example APOE-ε4 carriers) are the groups most likely to be connected to follow-up clinical research informed by this work.
Not a fit: People looking for immediate treatments, those with non-Alzheimer dementias, or patients in very advanced stages of disease are unlikely to get direct benefit from this basic-lab project.
Why it matters
Potential benefit: If successful, this work could reveal early brain-circuit targets to slow or prevent progression of Alzheimer's disease.
How similar studies have performed: Previous animal studies have found early circuit hyperexcitability and some preclinical benefits from targeting interneurons, but the automated, cell-type-specific electrophysiology methods used here are relatively new.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ROWAN, MATTHEW J.M. — EMORY UNIVERSITY
- Study coordinator: ROWAN, MATTHEW J.M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome